IP3K Inhibitor,
519178-28-0,
CHEMBL467591,
TNP,
N6-[(4-nitrophenyl)methyl]-N2-[[3-(trifluoromethyl)phenyl]methyl]-9H-Purine-2,6-diamine,
Inositol-1,4,5-trisphosphate 3-Kinase Inhibitor,
N2-(m-Trifluorobenzyl), N6-(p-nitrobenzyl)purine,
Purine, 5,
SCHEMBL14234675,
SCHEMBL14235423,
BDBM82310,
CTK8E6629,
DTXSID60587903,
HMS3229H05,
HMS3260M17,
TNP, >=95% (HPLC),
Tox21_500068,
BDBM50261491,
IN1452,
ZINC16052813,
AKOS024457890,
CCG-221372,
NCGC00260753-01,
NCGC00378815-01,
HY-110079,
RT-013349,
B7547,
CS-0032922,
N2-(3-(trifluoromethyl)benzyl)-N6-(4-nitrobenzyl)-9H-purine-2,6-diamine,
N~6~-[(4-Nitrophenyl)methyl]-N~2~-{[3-(trifluoromethyl)phenyl]methyl}-7H-purine-2,6-diamine,
N2-(m-Trifluorobenzyl), N6-(p-nitrobenzyl)purine; N6-[(4-nitrophenyl)methyl]-N2-[[3-(trifluoromethyl)phenyl]methyl]-9H-Purine-2,6-diamine; N6-[(4-nitrophenyl)methyl]-N2-[[3-(trifluoromethyl)phenyl]methyl]-1H-Purine-2,6-diamine,